Litigation Details for Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)
✉ Email this page to a colleague
Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-12-03 |
Court | District Court, D. Delaware | Date Terminated | 2024-04-01 |
Cause | 35:271 Patent Infringement | Assigned To | Stephanos Bibas |
Jury Demand | Defendant | Referred To | |
Patents | 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; 8,709,478 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Galderma Laboratories L.P. v. Lupin Inc.
Details for Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-04-07 | 108 | Opinion - Memorandum Opinion | pharmaceutically acceptable excipients. U.S. Patent No. 8,206,740 cl. 1. Sun already construed the terms…company, Sun, for infringing the same patents. Many of the patents’ terms were construed in that suit. … slowly. Galderma patented its developments. Though Galderma has several patents and dozens of claims… “It is a bedrock principle of patent law that the claims of a patent define the in- vention to which…Galderma says Lupin infringes some of its drug patents. A few years ago, Gal- derma won a lawsuit against | External link to document |
2023-04-07 | 109 | Order | ORDER Regarding Terms of US Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; …2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
2023-05-10 | 116 | Stipulation of Dismissal | of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478 by …2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |